Viridien
Short position disclosed on October 21, 2026.
Evolution of the disclosed total
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Marshall Wace LLP | 1.99% | unchanged | October 20, 2026 | ||
| Capital Fund Management | 1.69% | new | October 19, 2026 | ||
| Citadel Advisors LLC | 1.46% | new | October 21, 2026 | ||
| Worldquant, LLC | 1.29% | new | October 15, 2026 | ||
| Acadian Asset Management LLC | 1.10% | new | October 19, 2026 | ||
| Tudor Capital Europe LLP | 0.80% | new | October 1, 2026 | ||
| Walleye Capital LLC | 0.80% | new | October 5, 2026 | ||
| TWO Sigma Investments, LP | 0.79% | new | October 19, 2026 | ||
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | AMF |
In the United States CGPVF (OTC): 15,164 shares sold short on September 30, 2026. FINRA names no fund.
On the other side: the funds that hold Viridien Titelia
Get the moves on Viridien by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| February 18, 2014 | Marshall Wace LLP | 0.91% | April 18, 2014 | |
| February 13, 2014 | Marshall Wace LLP | 0.83% | April 18, 2014 | |
| February 12, 2014 | Marshall Wace LLP | 0.78% | April 18, 2014 | |
| February 11, 2014 | Marshall Wace LLP | 0.80% | April 18, 2014 | |
| February 11, 2014 | Jpmorgan Asset Management (UK) Limited | 0.55% | November 24, 2014 | |
| February 7, 2014 | Bluecrest Capital Management Limited | 0.55% | February 27, 2014 | |
| February 6, 2014 | AQR Capital Management, LLC | 1.40% | September 16, 2015 | |
| February 6, 2014 | Marshall Wace LLP | 0.76% | April 18, 2014 | |
| February 3, 2014 | AQR Capital Management, LLC | 1.30% | September 16, 2015 | |
| February 3, 2014 | Bluecrest Capital Management Limited | 0.61% | February 27, 2014 | |
| January 28, 2014 | AQR Capital Management, LLC | 1.21% | September 16, 2015 | |
| January 22, 2014 | Bluecrest Capital Management Limited | 0.59% | February 27, 2014 | |
| January 21, 2014 | Jpmorgan Asset Management (UK) Limited | 0.62% | November 24, 2014 | |
| January 20, 2014 | Jpmorgan Asset Management (UK) Limited | 0.56% | November 24, 2014 | |
| January 17, 2014 | Marshall Wace LLP | 0.88% | April 18, 2014 | |
| January 14, 2014 | Marshall Wace LLP | 0.96% | April 18, 2014 | |
| January 9, 2014 | AQR Capital Management, LLC | 1.12% | September 16, 2015 | |
| January 9, 2014 | AKO Capital LLP | 0.71% | May 12, 2014 | |
| January 9, 2014 | Bluecrest Capital Management Limited | 0.61% | February 27, 2014 | |
| January 8, 2014 | AKO Capital LLP | 0.97% | May 12, 2014 | |
| January 7, 2014 | AKO Capital LLP | 1.19% | May 12, 2014 | |
| January 6, 2014 | AQR Capital Management, LLC | 1.02% | September 16, 2015 | |
| January 6, 2014 | Bluecrest Capital Management Limited | 0.50% | February 27, 2014 | |
| December 27, 2013 | AQR Capital Management, LLC | 0.98% | September 16, 2015 | |
| December 23, 2013 | Marshall Wace LLP | 1.04% | April 18, 2014 | |
| December 20, 2013 | Marshall Wace LLP | 0.99% | April 18, 2014 | |
| December 19, 2013 | Marshall Wace LLP | 0.85% | April 18, 2014 | |
| December 18, 2013 | Marshall Wace LLP | 0.65% | April 18, 2014 | |
| December 18, 2013 | Blackrock Investment Management (UK) Limited | 0.31% | December 20, 2013 | |
| December 17, 2013 | AKO Capital LLP | 1.26% | May 12, 2014 | |
| December 16, 2013 | AQR Capital Management, LLC | 1.02% | September 16, 2015 | |
| December 16, 2013 | Blackrock Investment Management (UK) Limited | 0.58% | December 20, 2013 | |
| December 10, 2013 | Marshall Wace LLP | 0.70% | April 18, 2014 | |
| December 10, 2013 | Blackrock Investment Management (UK) Limited | 0.61% | December 20, 2013 | |
| December 6, 2013 | Marshall Wace LLP | 0.60% | April 18, 2014 | |
| December 3, 2013 | AQR Capital Management, LLC | 0.92% | September 16, 2015 | |
| December 3, 2013 | Marshall Wace LLP | 0.54% | April 18, 2014 | |
| December 2, 2013 | Blackrock Investment Management (UK) Limited | 0.59% | December 20, 2013 | |
| November 29, 2013 | AKO Capital LLP | 1.51% | May 12, 2014 | |
| November 29, 2013 | Blackrock Investment Management (UK) Limited | 0.60% | December 20, 2013 | |
| November 28, 2013 | AKO Capital LLP | 1.29% | May 12, 2014 | |
| November 27, 2013 | AKO Capital LLP | 1.12% | May 12, 2014 | |
| November 26, 2013 | AKO Capital LLP | 1.05% | May 12, 2014 | |
| November 25, 2013 | AKO Capital LLP | 0.91% | May 12, 2014 | |
| November 21, 2013 | AKO Capital LLP | 0.72% | May 12, 2014 | |
| November 21, 2013 | Citadel Europe LLP | 0.46% | November 25, 2013 | |
| November 20, 2013 | Citadel Europe LLP | 0.76% | November 25, 2013 | |
| November 15, 2013 | Citadel Europe LLP | 0.89% | November 25, 2013 | |
| November 12, 2013 | Blackrock Investment Management (UK) Limited | 0.80% | December 20, 2013 | |
| November 11, 2013 | Marshall Wace LLP | 0.48% | November 13, 2013 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 2,528 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.60% of the capital sold short
- Valeo 11.47% of the capital sold short
- Ubisoft Entertainment 10.77% of the capital sold short
- FDJ United 6.58% of the capital sold short
- Teleperformance 5.88% of the capital sold short
- Abivax 5.53% of the capital sold short
- Alstom 4.98% of the capital sold short
- Rémy Cointreau 4.66% of the capital sold short
- Atos Group 3.73% of the capital sold short
- DBV Technologies 3.39% of the capital sold short
- Gecina 3.32% of the capital sold short
- Forvia 3.25% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at October 21, 2026, https://www.quivad.com/action/viridien?page=50